A community-partnered approach for diversity in COVID-19 vaccine clinical trials.

Yelba M Castellon-LopezRaphael LandovitzEjiro NtekumeCourtney PorterRachelle BrossRobin HilderAziza Lucas-WrightEric S DaarPedro ChavezChristopher BladesSavanna L CarsonD'Ann MorrisStefanie VassarAlejandra CasillasArleen F Brown

Published in: Journal of clinical and translational science (2022)

Using deliberative community engagement can provide critical and timely insight into the community-centered barriers to COVID-19 vaccine trial participation, including addressing social determinants of health, trust, clinical trial literacy, structural barriers, and identifying trusted messenger and reliable sources of information.

Keyphrases

human health
clinical trial
coronavirus disease
mental health
healthcare
sars cov
health information
phase ii
phase iii
study protocol
social media
open label
physical activity
public health
drinking water